Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Phase II Study Of Oxaliplatin Single Agent As Third-Line Treatment Of Metastatic Colorectal Carcinoma

NCT00017082 is registered in ClinicalTrials.gov with Prologue Research International as lead sponsor.

NCT NCT00017082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00017082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Phase II Study Of Oxaliplatin Single Agent As Third-Line Treatment Of Metastatic Colorectal Carcinoma
Lead sponsor
Prologue Research International
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2001
Completion date
December 31, 2010
Enrollment
Not reported
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer